These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15886815)

  • 1. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study.
    Lawlor DA; Smith GD; Rumley A; Lowe GD; Ebrahim S
    Thromb Haemost; 2005 May; 93(5):955-63. PubMed ID: 15886815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse socioeconomic position across the lifecourse increases coronary heart disease risk cumulatively: findings from the British women's heart and health study.
    Lawlor DA; Ebrahim S; Davey Smith G
    J Epidemiol Community Health; 2005 Sep; 59(9):785-93. PubMed ID: 16100318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project.
    Jousilahti P; Salomaa V; Rasi V; Vahtera E; Palosuo T
    Atherosclerosis; 2001 Jun; 156(2):451-6. PubMed ID: 11395043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of components of adult height with coronary heart disease in postmenopausal women: the British women's heart and health study.
    Lawlor DA; Taylor M; Davey Smith G; Gunnell D; Ebrahim S
    Heart; 2004 Jul; 90(7):745-9. PubMed ID: 15201241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.
    May M; Lawlor DA; Patel R; Rumley A; Lowe G; Ebrahim S
    Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):638-45. PubMed ID: 17925622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of low socioeconomic status to C-reactive protein in patients with coronary heart disease (from the heart and soul study).
    Lubbock LA; Goh A; Ali S; Ritchie J; Whooley MA
    Am J Cardiol; 2005 Dec; 96(11):1506-11. PubMed ID: 16310431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.
    Danesh J; Collins R; Appleby P; Peto R
    JAMA; 1998 May; 279(18):1477-82. PubMed ID: 9600484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and incident coronary heart disease: results from the British Women's Heart and Health Study.
    Fraser A; May M; Lowe G; Rumley A; Smith GD; Ebrahim S; Lawlor DA
    Atherosclerosis; 2009 Feb; 202(2):567-72. PubMed ID: 18556001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.
    Folsom AR; Aleksic N; Catellier D; Juneja HS; Wu KK
    Am Heart J; 2002 Aug; 144(2):233-8. PubMed ID: 12177639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's exposure to early and later life socioeconomic disadvantage and coronary heart disease risk: the Stockholm Female Coronary Risk Study.
    Wamala SP; Lynch J; Kaplan GA
    Int J Epidemiol; 2001 Apr; 30(2):275-84. PubMed ID: 11369727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: findings from the prospective British Women's Heart and Health Study.
    Lawlor DA; Ebrahim S; Smith GD; Cherry L; Watt P; Sattar N
    Atherosclerosis; 2008 Nov; 201(1):198-204. PubMed ID: 18295769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
    Coutinho Tde A; Turner ST; Peyser PA; Bielak LF; Sheedy PF; Kullo IJ
    Am J Hypertens; 2007 Jan; 20(1):83-9. PubMed ID: 17198917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep duration, C-reactive protein and risk of incident coronary heart disease--results from the Framingham Offspring Study.
    Liu J; Yuen J; Kang S
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):600-5. PubMed ID: 24548663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EN-RAGE: a novel inflammatory marker for incident coronary heart disease.
    Ligthart S; Sedaghat S; Ikram MA; Hofman A; Franco OH; Dehghan A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2695-9. PubMed ID: 25341801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
    Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
    J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.
    Onat A; Can G; Hergenç G; Uğur M; Yüksel H
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.